These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8642569)

  • 21. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
    Kam YL; Ro JY; Kim HJ; Choo HY
    Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species.
    Félétou M; Germain M; Thurieau C; Fauchère JL; Canet E
    Br J Pharmacol; 1994 Jun; 112(2):683-9. PubMed ID: 8075888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid-phase synthesis of MEN 11270, a new cyclic peptide kinin B2 receptor antagonist.
    Anichini B; Ricci R; Fabbri G; Balacco G; Mauro S; Triolo A; Altamura M; Maggi CA; Quartara L
    J Pept Sci; 2000 Dec; 6(12):612-20. PubMed ID: 11192241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and characterization of bradykinin B(2) receptor agonists containing constrained dipeptide mimics.
    Amblard M; Daffix I; Bergé G; Calmès M; Dodey P; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Martinez J
    J Med Chem; 1999 Oct; 42(20):4193-201. PubMed ID: 10514289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
    J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic pentapeptides of chiral sequence DLDDL as scaffold for antagonism of G-protein coupled receptors: synthesis, activity and conformational analysis by NMR and molecular dynamics of ITF 1565 a substance P inhibitor.
    Porcelli M; Casu M; Lai A; Saba G; Pinori M; Cappelletti S; Mascagni P
    Biopolymers; 1999 Aug; 50(2):211-9. PubMed ID: 10380345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2.
    Tiritilli A; El Habach T; Haury L; Duret JF
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):247-52. PubMed ID: 15319801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
    Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
    Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
    Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
    J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
    Wiernas TK; Griffin BW; Sharif NA
    Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural characterization of lipopeptide agonists for the bradykinin B2 receptor.
    Giragossian C; Nardi E; Savery C; Pellegrini M; Meini S; Maggi CA; Papini AM; Mierke DF
    Biopolymers; 2001 Apr; 58(5):511-20. PubMed ID: 11241222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
    Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor.
    Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
    Br J Pharmacol; 1998 Sep; 125(2):365-72. PubMed ID: 9786510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.